ATE458997T1 - Tiermodell zur analyse von tumormetastasierung - Google Patents

Tiermodell zur analyse von tumormetastasierung

Info

Publication number
ATE458997T1
ATE458997T1 AT04776817T AT04776817T ATE458997T1 AT E458997 T1 ATE458997 T1 AT E458997T1 AT 04776817 T AT04776817 T AT 04776817T AT 04776817 T AT04776817 T AT 04776817T AT E458997 T1 ATE458997 T1 AT E458997T1
Authority
AT
Austria
Prior art keywords
tumor metastasis
animal model
analyzing tumor
study
analyzing
Prior art date
Application number
AT04776817T
Other languages
English (en)
Inventor
Masato Nakamura
Yasuyuki Ohnishi
Original Assignee
Central Inst Exper Animals
Ct For The Advancement Of Heal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Inst Exper Animals, Ct For The Advancement Of Heal filed Critical Central Inst Exper Animals
Application granted granted Critical
Publication of ATE458997T1 publication Critical patent/ATE458997T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Toxicology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
AT04776817T 2003-07-10 2004-06-18 Tiermodell zur analyse von tumormetastasierung ATE458997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48704403P 2003-07-10 2003-07-10
PCT/US2004/019697 WO2005013682A2 (en) 2003-07-10 2004-06-18 Animal model for the analysis of tumor metastasis

Publications (1)

Publication Number Publication Date
ATE458997T1 true ATE458997T1 (de) 2010-03-15

Family

ID=34135078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04776817T ATE458997T1 (de) 2003-07-10 2004-06-18 Tiermodell zur analyse von tumormetastasierung

Country Status (8)

Country Link
US (1) US20050132427A1 (de)
EP (1) EP1644732B1 (de)
JP (2) JP4663634B2 (de)
AT (1) ATE458997T1 (de)
AU (1) AU2004263079A1 (de)
CA (1) CA2531916A1 (de)
DE (1) DE602004025706D1 (de)
WO (1) WO2005013682A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008514205A (ja) * 2004-09-29 2008-05-08 財団法人実験動物中央研究所 Ｎｏｇマウスを用いた高転移性細胞株の樹立
CN1920564B (zh) * 2005-08-26 2011-08-24 中国科学院上海生命科学研究院 细胞转录因子ilf-1的应用
JP2007139656A (ja) * 2005-11-21 2007-06-07 Igaku Seibutsugaku Kenkyusho:Kk 食道癌診断キット
EP2027256A2 (de) * 2006-05-31 2009-02-25 Projech Science to Technology, S.L. Tiermodelle für tumormetastase und toxizität
DK2140269T3 (da) * 2007-03-27 2013-12-16 Immunovia Ab Proteinsignatur/markører til at detektere adenocarcinom
WO2010118782A1 (en) * 2009-04-17 2010-10-21 Universite Libre De Bruxelles Methods and tools for predicting the efficiency of anthracyclines in cancer
US20130309246A1 (en) * 2011-02-02 2013-11-21 The Trustees Of Princeton University Jagged1 as a marker and therapeutic target for breast cancer bone metastasis
CA2841404C (en) * 2011-02-11 2022-04-26 Sohail TAVAZOIE Treatment of angiogenesis disorders
WO2013035779A1 (ja) * 2011-09-06 2013-03-14 国立大学法人東京大学 細胞間の相互作用の解析方法
EP3310159A4 (de) 2015-06-16 2019-02-20 The Jackson Laboratory Genetisch veränderte nichtmenschliche tiere und verfahren zur komplementabhängigen zytotoxizität
TWI810145B (zh) 2015-06-23 2023-08-01 杰克森實驗室 具有病患衍生之異種移植物之非ｈｌａ配對的人源化ｎｓｇ小鼠模式
KR101992817B1 (ko) * 2016-02-15 2019-09-30 고려대학교 산학협력단 폐암 동물모델의 제조방법
WO2017142292A1 (ko) * 2016-02-15 2017-08-24 고려대학교 산학협력단 폐암 동물모델의 제조방법
RU2725273C1 (ru) * 2019-11-05 2020-06-30 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии" Министерства здравоохранения Российской Федерации Способ трансплантации фрагмента нейроэндокринной опухоли поджелудочной железы человека в поджелудочную железу иммунодефицитных мышей
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
PT118269A (pt) 2022-10-20 2024-04-22 Univ Aveiro Pkmyt1 for use in regenerative medicine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402459A1 (en) * 2000-12-01 2002-06-06 Central Institute For Experimental Animals Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse
US7135609B2 (en) * 2001-05-10 2006-11-14 Chugai Seiyaku Kabushiki Kaisha Non-human animal exhibiting bone metastasis of tumor cells and method of screening for bone metastasis inhibitors

Also Published As

Publication number Publication date
US20050132427A1 (en) 2005-06-16
JP2007527216A (ja) 2007-09-27
AU2004263079A1 (en) 2005-02-17
CA2531916A1 (en) 2005-02-17
EP1644732B1 (de) 2010-02-24
DE602004025706D1 (de) 2010-04-08
JP2011030570A (ja) 2011-02-17
JP4663634B2 (ja) 2011-04-06
WO2005013682A3 (en) 2005-07-28
WO2005013682A2 (en) 2005-02-17
EP1644732A2 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
ATE458997T1 (de) Tiermodell zur analyse von tumormetastasierung
BR0210918A (pt) Método e aparelho para personalizar ração para animal de estimação
ATE365912T1 (de) Mr-verfahren zur analyse von samen
ATE343937T1 (de) Halter für simulierten rauchartikel
EP1615993A4 (de) Verfahren zur selektion, aufzeichnung und analyse genetischer marker unter verwendung von anwendungen zur erstellung genetischer profile auf breiter grundlage
DE602004025531D1 (de) Ng, programm zur schlüsselworterkennung, mit adaption von schlüsselwort- und nichtschlüsselwortmodellen.
WO2006039678A3 (en) Establishment of highly metastatic cell lines using nog mice
ATE516842T1 (de) Intravasculärer führungsdraht
DE60322426D1 (de)
ATE438739T1 (de) Verfahren und zusammensetzungen zur analyse von ahasl-genen
DE60231665D1 (de) Agarwood aus kulturmässigem Anbau
DE602006008581D1 (de) Verfahren zur bestimmung von montagebedingungen, vorrichtung zur bestimmung von montagebedingungen und montagevorrichtung
DE602004006020D1 (de) Verwendung von n-arylhydrazinderivaten für die bekämpfung von schädlingen , welche kulturpflanzen nicht angreifen
DK1331855T3 (da) Husdyrdiætfoder til ældre dyr
DE60302814D1 (de) Vorrichtung für eine tierbezogene Handlung
DE602004009824D1 (de) Analyse von massenspektraldaten in den ruhigen gebieten
DE60126479D1 (de) Vorrichtung zur mehrwertigen Modulation
SE0300002L (sv) Ny produkt
ATE329019T1 (de) Verfahren zur herstellung von klonierten vögeln
DE602006020224D1 (de) Kleine Vorrichtung zur Analyse von Genen
DE60320172D1 (de) Vorrichtung zur autonomen Bodenbearbeitung
FI20010782A0 (fi) Parannettu metsälannoite
BRPI0203260B1 (pt) processo de curtimento de pele.
DE60216332D1 (de) Antioxydationsmittel aus natürlicher quelle
DE60321248D1 (de) Verwendung von pollen-isolierten proteinen zur inhibierung der aktivität des anthrax-toxins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties